What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Stroke
- Surgery
Marc Fisher focuses on Stroke, Internal medicine, Ischemia, Clinical trial and Intensive care medicine.
Marc Fisher interconnects Physical therapy, Surgery and Infarction in the investigation of issues within Stroke.
His Internal medicine study incorporates themes from Placebo, Endocrinology and Cardiology.
Marc Fisher has included themes like Effective diffusion coefficient, Magnetic resonance imaging, Perfusion and Pathology in his Ischemia study.
His Clinical trial research is multidisciplinary, incorporating perspectives in Effective treatment, Amantadine, MEDLINE, Randomized controlled trial and Neuroprotection.
His Intensive care medicine study integrates concerns from other disciplines, such as Thrombolysis, Acute stroke and Outbreak.
His most cited work include:
- Vascular dementia Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop* (3919 citations)
- Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (3624 citations)
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations (907 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Stroke, Internal medicine, Ischemia, Cardiology and Intensive care medicine.
The Stroke study combines topics in areas such as Anesthesia, Clinical trial, Surgery, Magnetic resonance imaging and Physical therapy.
In his study, Tissue plasminogen activator is strongly linked to Thrombolysis, which falls under the umbrella field of Surgery.
Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Endocrinology.
His studies in Ischemia integrate themes in fields like Effective diffusion coefficient, Occlusion, Perfusion and Pathology.
The study of Intensive care medicine is intertwined with the study of MEDLINE in a number of ways.
He most often published in these fields:
- Stroke (54.60%)
- Internal medicine (29.55%)
- Ischemia (21.41%)
What were the highlights of his more recent work (between 2017-2021)?
- Stroke (54.60%)
- Internal medicine (29.55%)
- Cardiology (20.77%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Stroke, Internal medicine, Cardiology, Acute ischemic stroke and Intensive care medicine.
His study in Stroke is interdisciplinary in nature, drawing from both Neurology, Clinical trial, MEDLINE and Emergency medicine.
His Clinical trial research incorporates themes from Magnetic resonance imaging and Informed consent.
His Cardiology research includes elements of Cardioembolic stroke, Ischemic stroke, Angiography and Intracranial haemorrhage.
His study on Acute ischemic stroke also encompasses disciplines like
- Thrombolysis and related Endovascular treatment,
- Core that intertwine with fields like Gold standard and Computed tomography,
- Endovascular therapy that connect with fields like Perfusion.
Marc Fisher usually deals with Intensive care medicine and limits it to topics linked to Stroke treatment and Cytoprotection and Triage.
Between 2017 and 2021, his most popular works were:
- Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions. (112 citations)
- Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era. (33 citations)
- Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016 (19 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His main research concerns Stroke, Intensive care medicine, Acute ischemic stroke, Stroke treatment and Emergency medicine.
His Stroke study combines topics in areas such as Receptor and PI3K/AKT/mTOR pathway.
Marc Fisher has researched Intensive care medicine in several fields, including Iv thrombolysis and Treatment modality.
His biological study spans a wide range of topics, including Endovascular treatment, Thrombolysis, Clinical trial and Magnetic resonance imaging.
His Emergency medicine study integrates concerns from other disciplines, such as Anticoagulant, Nursing homes, Acute stroke and 2019-20 coronavirus outbreak.
His work carried out in the field of Core brings together such families of science as Internal medicine and Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
